Subscribe
hynci-istockphoto-com-dollars-cash-
hynci / iStockphoto.com
13 August 2018Americas

PhRMA members invested $71.4bn in R&D in 2017

Members of the Pharmaceutical Research and Manufacturers of America (PhRMA) last year obtained the highest-ever level of investment for the industry group, recording $71.4 billion of funding in research and development (R&D).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
PhRMA cuts membership, increases R&D requirements
11 May 2017   The Pharmaceutical Research and Manufacturers of America has cut 22 members based on a new set of membership criteria it introduced on Tuesday, May 9.
Americas
PhRMA shames Brazil and Thailand over patent backlogs
6 November 2018   Pharmaceutical Research and Manufacturers of America has identified Brazil and Thailand as two of the worst countries for patent delays, in a submission made to a US government report.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Americas
PhRMA cuts membership, increases R&D requirements
11 May 2017   The Pharmaceutical Research and Manufacturers of America has cut 22 members based on a new set of membership criteria it introduced on Tuesday, May 9.
Americas
PhRMA shames Brazil and Thailand over patent backlogs
6 November 2018   Pharmaceutical Research and Manufacturers of America has identified Brazil and Thailand as two of the worst countries for patent delays, in a submission made to a US government report.

More on this story

Americas
PhRMA cuts membership, increases R&D requirements
11 May 2017   The Pharmaceutical Research and Manufacturers of America has cut 22 members based on a new set of membership criteria it introduced on Tuesday, May 9.
Americas
PhRMA shames Brazil and Thailand over patent backlogs
6 November 2018   Pharmaceutical Research and Manufacturers of America has identified Brazil and Thailand as two of the worst countries for patent delays, in a submission made to a US government report.

More features

President Trump 2.0: Five major areas to watch
China’s new policies on foreign investment in healthcare and biotech
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug